Figure 1From: RETRACTED ARTICLE: A synthetic dsRNA, as a TLR3 pathwaysynergist, combined with sorafenib suppresses HCC in vitro and in vivo TLR3 and NF-κB mRNA expressions. The expressions of TLR3 and NF-κB were determined by RT-qPCR in HepG2.2.15 cells treated with five different dsRNAs. The values in the figure are normalized to PBS treatment (1.00). *, p < 0.05 compared to the PBS control group; #, p < 0.05 compared to the BM-06 group.Back to article page